ES8304430A1 - "un procedimiento para obtener insulina humana". - Google Patents

"un procedimiento para obtener insulina humana".

Info

Publication number
ES8304430A1
ES8304430A1 ES513522A ES513522A ES8304430A1 ES 8304430 A1 ES8304430 A1 ES 8304430A1 ES 513522 A ES513522 A ES 513522A ES 513522 A ES513522 A ES 513522A ES 8304430 A1 ES8304430 A1 ES 8304430A1
Authority
ES
Spain
Prior art keywords
human
human proinsulin
preproinsulin
recombinant plasmids
host
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES513522A
Other languages
English (en)
Other versions
ES513522A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis Vaccines and Diagnostics Inc
Original Assignee
Cetus Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cetus Corp filed Critical Cetus Corp
Publication of ES513522A0 publication Critical patent/ES513522A0/es
Publication of ES8304430A1 publication Critical patent/ES8304430A1/es
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C12N15/625—DNA sequences coding for fusion proteins containing a sequence coding for a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/62—Insulins
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE INSULINA HUMANA. CONSISTE EN LA TRANSFORMACION DE UN ORGANISMO HOSPEDANTE CAPAZ DE CONVERTIR PREPROINSULINA EN PROINSULINA HUMANA ~AIN VIVO~B, MEDIANTE UN VECTOR DE CLONACION QUE CONTIENE UNA SECUENCIA DE PREPROINSULINA; TRANSPORTE DE LA PROINSULINA HUMANA A TRAVES DE LA MEMBRANA CELULAR DEL HOSPEDANTE, QUE SE DESARROLLA EN CONDICIONES ADECUADAS PARA LA EXPRESION DE UNA SECUENCIA DE ADN QUE CODIFICA UN PRODUCTO PEPTIDICO DE PREPROINSULINA; CONVERSION DEL PEPTIDO EN PROINSULINA HUMANA ~AIN VIVO~B POR EL ORGANISMO HOSPEDANTE TRANSFORMADO; ACUMULACION Y RECUPERACION DE LA PROINSULINA HUMANA; Y TRANSFORMACION DE ESTA EN INSULINA HUMANA ~AIN VITRO~B. LA INSULINA TIENE APLICACIONES FARMACOLOGICAS PARA EL TRATAMIENTO DE LA DIABETES.
ES513522A 1981-06-29 1982-06-28 "un procedimiento para obtener insulina humana". Expired ES8304430A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US27833181A 1981-06-29 1981-06-29

Publications (2)

Publication Number Publication Date
ES513522A0 ES513522A0 (es) 1983-03-01
ES8304430A1 true ES8304430A1 (es) 1983-03-01

Family

ID=23064574

Family Applications (1)

Application Number Title Priority Date Filing Date
ES513522A Expired ES8304430A1 (es) 1981-06-29 1982-06-28 "un procedimiento para obtener insulina humana".

Country Status (12)

Country Link
US (1) USH245H (es)
EP (1) EP0070632A3 (es)
JP (1) JPS58501227A (es)
AU (1) AU556980B2 (es)
CA (1) CA1201074A (es)
DK (1) DK84583A (es)
ES (1) ES8304430A1 (es)
IL (1) IL66102A0 (es)
NO (1) NO830682L (es)
PT (1) PT75075B (es)
WO (1) WO1983000164A1 (es)
ZA (1) ZA824218B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0090433A1 (en) * 1982-03-31 1983-10-05 Genetics Institute, Inc. Creation of DNA sequences encoding modified proinsulin precursors
DE3245665A1 (de) * 1982-05-04 1983-11-10 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren zur herstellung permanenter tierischer und humaner zellinien und deren verwendung
US5670371A (en) * 1983-07-15 1997-09-23 Bio-Technology General Corp. Bacterial expression of superoxide dismutase
DK58285D0 (da) * 1984-05-30 1985-02-08 Novo Industri As Peptider samt fremstilling og anvendelse deraf
US4767709A (en) 1984-06-28 1988-08-30 The Johns Hopkins University Growth-related hormones
PH25772A (en) * 1985-08-30 1991-10-18 Novo Industri As Insulin analogues, process for their preparation
US5496924A (en) * 1985-11-27 1996-03-05 Hoechst Aktiengesellschaft Fusion protein comprising an interleukin-2 fragment ballast portion
DE3752347T2 (de) * 1986-05-20 2002-09-26 The General Hospital Corp., Boston Verfahren zur pharmakokinetischen Studie der Insulin-Expression mit nicht-menschlichem Transgen-Säugetier
US6348327B1 (en) * 1991-12-06 2002-02-19 Genentech, Inc. Non-endocrine animal host cells capable of expressing variant proinsulin and processing the same to form active, mature insulin and methods of culturing such cells
US6001604A (en) * 1993-12-29 1999-12-14 Bio-Technology General Corp. Refolding of proinsulins without addition of reducing agents
US20180057920A1 (en) * 2016-08-31 2018-03-01 General Electric Company Grain refinement in in706 using laves phase precipitation

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5210872B2 (es) * 1973-07-14 1977-03-26
US4082613A (en) * 1976-04-23 1978-04-04 The Regents Of The University Of Minnesota Process for the production of insulin by genetically transformed fungal cells
US4411994A (en) * 1978-06-08 1983-10-25 The President And Fellows Of Harvard College Protein synthesis
FI792481A7 (fi) * 1978-08-11 1981-01-01 The Regents Of The Univ Of Enkaroyyttisen proteiinin synteesi mikro-organismia käyttäen.
GR70279B (es) * 1979-09-12 1982-09-03 Univ California
DE3001928A1 (de) * 1980-01-19 1981-08-06 Hoechst Ag, 6000 Frankfurt Genprodukt eines hoeheren organismus aus einem dieses gen enthaltenden mikroorganismus
EP0036258A3 (en) 1980-03-14 1982-02-10 Cetus Corporation Process for producing aspartame
US4338397A (en) * 1980-04-11 1982-07-06 President And Fellows Of Harvard College Mature protein synthesis
DK582381A (da) * 1981-01-02 1982-07-03 Univ New York Remkombinat plasmid til anvendelse ved bakteriel kloning

Also Published As

Publication number Publication date
PT75075A (en) 1982-07-01
WO1983000164A1 (en) 1983-01-20
USH245H (en) 1987-04-07
ES513522A0 (es) 1983-03-01
PT75075B (en) 1983-12-28
IL66102A0 (en) 1982-09-30
EP0070632A2 (en) 1983-01-26
NO830682L (no) 1983-02-28
AU8762382A (en) 1983-02-02
AU556980B2 (en) 1986-11-27
CA1201074A (en) 1986-02-25
DK84583D0 (da) 1983-02-24
ZA824218B (en) 1983-04-27
JPS58501227A (ja) 1983-07-28
EP0070632A3 (en) 1983-06-29
DK84583A (da) 1983-02-24

Similar Documents

Publication Publication Date Title
FI853056L (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
NO174351C (no) Fremgangsmåte for fremstilling av human insulinforlöper samt DNA-sekvens og vektor til anvendelse av fremgangsmåten
FR2681786B1 (es)
SG48422A1 (en) Yeast expression systems with vectors having gapdh promoters and synthesis of hbsag
ATE54167T1 (de) Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden.
ATE77104T1 (de) Menge und verfahren zur herstellung rekombinierter erzeugnisse in grosser ausbeute.
CZ285453B6 (cs) DNA, která obsahuje gen kódující aspartokinézu III, mikroorganizmus Escherichia coli a způsob výroby L-threoninu fermentací
JPS5777654A (en) Nonglycosylated interferon
IE940140L (en) Hybrid DNA synthesis of mature insulin-like growth factors
HUT43630A (en) Mammalian interleukine-4 and process for producing it
HK87584A (en) Bacterial plasmid encoding human growth hormone
GR862185B (en) Production of pluripotent granulocyte colony-stimulating factor
BG42527A3 (en) Method for preparing human immunic interferon
EP0070632A3 (en) Recombinant plasmids encoded for human preproinsulin and their use in producing human insulin
CA2001303A1 (en) Endothelin dna and use thereof
IL87748A0 (en) Structural gene coding for human serum albumin,its production and its use
EP0121884A3 (en) Hybrid dna synthesis of insulin
PT81872A (en) A process for preparing glucagon or derivatives thereof in a transformed yeast strain
EP0037723A3 (en) Expression of hormone genomic clones
DE3270874D1 (en) A process for producing a single cell protein material (scp), scp and biologically pure culture of yeast
ES8605813A1 (es) Procedimiento de tecnologia genetica para preparar interleu-quina-2 de humano
MY102257A (en) Production and use of a novel t-cell suppressor factor
EP0225860A3 (en) A method to export gene products to the growth medium of gram negative bacteria
AU8592582A (en) Closed dna loop used as expression vector of transferring a gene to a procaryote
ES2061524T3 (es) Un vector plasmidico para la expresion en bacillus y empleado para la clonacion del gen estructural que codifica la hormona de crecimiento humana y un metodo para la produccion de la hormona.